Joseph Klein III, Director at IONIS PHARMACEUTICALS INC (IONS), sold 4,000 shares at $80.00 ($320K) on 2025-11-25, disclosed to the SEC on 2025-11-28.
Scheduled sale ($320k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| IONS | SELL | 2026-04-02 | $1.7M | — | Filing → |
| IONS | SELL | 2026-03-05 | $3.4M | — | Filing → |
| IONS | SELL | 2025-09-04 | $1.7M | — | Filing → |